Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.30
Bid: 5.20
Ask: 5.25
Change: 0.545 (11.46%)
Spread: 0.05 (0.962%)
Open: 4.875
High: 5.69
Low: 4.70
Prev. Close: 4.755
SEE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Shares to Directors and Staff & TVR

19 Oct 2015 10:00

RNS Number : 6580C
Seeing Machines Limited
19 October 2015
 

Seeing Machines Limited

Issue of Shares to Directors and Staff

and Total Voting Rights

19 October 2015

Seeing Machines (AIM: SEE), the AIM-listed company with a focus on operator monitoring and intervention sensing technologies and services, announces that on 16 October the Board resolved to issue equity to directors and staff under the terms of the Company's share plan. In line with the Company's usual practice of conducting annual reviews of performance and remuneration, the Company is issuing equity to staff based on performance for the 2015 financial year. The Company is also issuing shares as part of the remuneration of non-executive directors.

Issues to Staff

The Company is making the following offers of equity to staff:

General staff offer: The first offer is a general offer of new fully paid ordinary shares of no par value ("New Ordinary Shares") to eligible staff who are not covered by the Company's other incentive schemes. These staff will each receive New Ordinary Shares equivalent to AUD 3,750 (GBP 1,774), pro-rated for staff who were not eligible for the full financial year. The issue price is 4.83 pence per share, being the average closing mid share price on AIM over the 5 trading days beginning on 21 September 2015, when the Company released its 2015 annual accounts. A total of 1,553,697 New Ordinary Shares will be issued to 81 staff. There are no loans for these shares and they vest on issue.

Executive Short Term Incentive: The second offer is an offer of New Ordinary Shares to nine executives as a short term incentive, and based on Company and personal KPI achievement for the 2015 financial year. The issue price is 4.83 pence per share, the same as the general staff offer. The number of shares issued to each executive varies based on their remuneration and performance. A total of 564,413 New Ordinary Shares will be issued under this offer. There are no loans for these shares and they vest on issue.

Executive Long Term Incentive - Performance Rights: The third tranche is an offer of performance rights to ten executives as a long term incentive. This does not involve the immediate issue of any New Ordinary Shares.

In recent years the Company has used a trust and loan structure as a long term incentive, whereby shares are issued up-front but held by a trustee, and the shares only vest for the benefit of executives if certain conditions are met (in which case the Company provided a loan to enable the executives to purchase their allocated shares). In July 2015 the Australian Government changed the tax laws governing employee equity plans, with the general effect that employees may now defer tax on equity offers in more circumstances, including when they receive performance rights or options. As a result of these changes, the Board has adopted performance rights as a long term incentive tool, instead of using a more complex trust and loan structure.

Consistent with recent long term offers, the executives are only able to exercise the rights, and have New Ordinary Shares issued to them, if, after three years from the end of the relevant financial year (i.e. for this offer, 1 July 2018): (a) the Company's share price meets a target share price set by the Board when it made the offer; and (b) the executive is still employed by the Company (subject to a limited number of exceptions). The rights vest in proportion to the target share price. If less than 90 percent of the target share price is achieved, then none of the rights vest.

If these conditions are met then the executive may exercise their rights and the Company will issue the number of New Ordinary Shares set out in the offer. The issue price of the New Ordinary Shares is 4.83 pence, consistent with the other offers. The number of rights offered to each executive varies based on their remuneration and performance. If all vesting conditions are met and all offers are exercised, a total of 5,965,559 New Ordinary Shares would be issued under these offers.

Executive Directors: Managing Director Ken Kroeger and Finance Director James Walker are participating in the 2nd and 3rd offers. Their shareholdings are described below:

Ken Kroeger

Ordinary shares

2,272,357

Held through Cook Kroeger Superannuation Fund

Long term incentive plan - vested

2,803,125

Shares issued in 2012, vested but still held by trustee

Long term incentive plan - not vested

4,089,628

Shares issued in 2013 & 2014, not vested

This offer - short term incentive

64,286

Ordinary shares

This offer - long term incentive

1,680,684

Performance rights, not vested

Sub-total - ordinary shares and vested

5,139,768

 

Total

10,910,080

Includes all unvested shares and performance rights

Represents approximately 1.15 percent of total voting rights in the Company

 

James Walker

Ordinary shares

600,000

Held through Kirri Cove Pty Limited

Long term incentive plan - not vested

2,691,532

Shares issued in 2013 & 2014, not vested

This offer - short term incentive

69,796

Ordinary shares

This offer - long term incentive

684,279

Performance rights, not vested

Sub-total - ordinary shares and vested

669,796

 

Total

4,045,607

Includes all unvested shares and performance rights

Represents approximately 0.42 percent of total voting rights in the Company

 

Issue of Shares to Non-Executive Directors

As foreshadowed in the 2014 Annual Report, during the 2015 financial year the Board re-structured non-executive directors' remuneration to include an equity component, in order to more closely align their interests with shareholders. Each non-executive director will receive 25 percent of their fee in the form of New Ordinary Shares, issued annually in arrears.

A total of 832,992 New Ordinary Shares will be issued in respect of the 2015 financial year, allocated to non-executive directors as set out in the table below. The issue price is 4.83 pence, the same as the offers of shares to staff.

Director

New Shares issued

New Total Shareholding

Percent of total voting rights

Terry Winters

260,310

1,892,476

0.20 %

David Gaul

130,155

3,530,155

0.37%

James Walker

156,186

156,186

0.01%

Rudy Burger

130,155

156,186

0.01%

Michael Roberts

156,186

5,151,562

0.54%

 

The value of the New Ordinary Shares is included in the cap on non-executive directors' remuneration as set out in the Company's Constitution.

 

Admission to AIM and Total Voting Rights

A total of 2,951,102 New Ordinary Shares will be issued to staff and directors under the offers described above. Application will be made for these 2,951,102 New Ordinary Shares to be admitted to trading on AIM. It is expected that admission will occur on 23 October 2015. Immediately following the admission of the New Ordinary Shares, the Company will have 943,929,411 ordinary shares in issue.

 

Enquiries:

Seeing Machines Limited

 

Ken Kroeger, Managing Director and CEO

+61 2 6103 4700

Ken.Kroeger@seeingmachines.com

 

James Walker, Finance Director

+61 2 6103 4700

James.Walker@seeingmachines.com

 

US media inquiries:

Troy Mickle

+1 415 218 3405

troy.mickle@seeingmachines.com

 

finnCap Ltd, Broker for Seeing Machines

Ed Frisby / Emily WattsCorporate Finance

+44 20 7220 0500

Joanna Weaving, Corporate Broking

 

 

Newgate, Investment Communications for Seeing Machines

Robyn McConnachie

 

Tim Thompson

 

Lois Engstrand

Tel: +44 20 7653 9852 / Mob: +44 7540 706 191

Robyn.mcconnachie@newgatecomms.com

 

Tel: +44 20 7653 9858 / Mob: +44 7710 718 649

Tim.thompson@newgatecomms.com

 

Tel: +44 20 7653 9844 / Mob: +44 7540 248 478

Lois.engstrand@newgatecomms.com

 

 

 

 

About Seeing Machines

Seeing Machines, (AIM: SEE) is focused on operator monitoring and intervention sensing technologies and services. With more than 15 years of experience, Seeing Machines uses advanced detection and prevention safety assistance technologies to track eye and facial movement in order to monitor fatigue, drowsiness and distraction events, such as microsleeps, texting and cell phone use as they occur, while providing for a real-time intervention strategy, which improves operator, driver and environmental safety, preserves assets, and reduces risk. Seeing Machines' technology is used worldwide across the automotive, mining, transport and aviation industries; as well as many of the leading academic research groups and transportation authorities. Seeing Machines is headquartered in Australia and has offices in Tucson, Arizona, Mountain View, California and Santiago, Chile. The Company has strategic alliances with Caterpillar, Electro Motive Diesel, Boeing, Takata, SEMCo and Eye Tracking Inc.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFFASAUFISEIS
Date   Source Headline
7th May 20247:00 amRNSQ3 FY2024 Quarterly KPIs
2nd May 202410:30 amRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSAutomotive Program Extension to 2032
26th Apr 202411:00 amRNSDirector/PDMR Shareholding
25th Mar 20248:06 amRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSHalf year results and financial report
28th Feb 20247:00 amRNSNotice of Results
8th Feb 20247:00 amRNSH1 FY2024 Trading Update & Quarterly KPIs
10th Jan 20247:00 amRNSNew Orders for Guardian Generation 3
9th Jan 20247:00 amRNSSeeing Machines unveils latest Guardian technology
3rd Jan 20247:00 amRNSSeeing Machines to showcase technology at CES 2024
20th Dec 20237:00 amRNSSeeing Machines announces US$30M European OEM win
13th Dec 20238:02 amRNSSeeing Machines welcomes U.S. NHTSA announcement
12th Dec 20237:00 amRNSSeeing Machines Wins Prestigious Road Safety Award
29th Nov 20237:57 amRNSResult of AGM
24th Nov 20237:00 amRNSAGM – reminder and correction of login details
8th Nov 20237:00 amRNS16th Automotive program awarded & Q1 FY2024 KPIs
6th Nov 202311:26 amRNSDirector/PDMR Shareholding
31st Oct 202311:50 amRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSNotice of AGM
27th Oct 20237:19 amRNSDirector/PDMR Shareholding
27th Oct 20237:13 amRNSDirector/PDMR Shareholding
25th Oct 20237:55 amRNSDirector/PDMR Shareholding
25th Oct 20237:00 amRNSBoard Changes
20th Oct 20239:30 amRNSDirector/PDMR Shareholding
20th Oct 20239:21 amRNSDirector/PDMR Shareholding
19th Oct 20238:47 amRNSDirector/PDMR Shareholding
18th Oct 202310:06 amRNSDirector/PDMR Shareholding
17th Oct 20239:41 amRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSYear End Results – FY2023
16th Oct 20237:00 amRNSDevelopment of aviation fatigue detection solution
14th Sep 20237:00 amRNSNotice of Full Year Results 2023
7th Sep 20235:31 pmRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSFY2023 Trading Update & Q4 KPIs
18th Jul 20237:30 amRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSCEO Incentive Plan
28th Jun 20231:44 pmRNSDirector/PDMR Shareholding
28th Jun 20237:00 amRNSDirector/PDMR Shareholding
26th Jun 202311:38 amRNSDirector/PDMR Shareholding
23rd Jun 20238:55 amRNSDirector/PDMR Shareholding
20th Jun 20237:30 amRNSCollaboration with synthetic data specialist
19th Jun 20238:00 amRNSSeeing Machines to attend Stifel Tech Conference
25th May 20239:53 amRNSDirector/PDMR Shareholding
22nd May 20239:46 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSExclusive Agreement Signed with Collins Aerospace
4th May 20237:00 amRNSKey Performance Indicators Q3 FY2023
17th Apr 20239:29 amRNSDirector/PDMR Shareholding
13th Apr 202312:36 pmRNSDirector/PDMR Shareholding
11th Apr 202311:15 amRNSPDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.